Bioline | GenomeWeb

Bioline

Meridian's Diagnostics segment grew 2 percent lifted by a 10 percent increase in revenues from the illumigene molecular product line.

NEW YORK (GenomeWeb) ― Tracking immunity and virus shedding after oral polio vaccination usually requires culture of poliovirus from stool samples.

NEW YORK (GenomeWeb) – Meridian Bioscience today reported a slight improvement in its fiscal third quarter sales as it missed consensus Wall Street expectations on the top and bottom lines.

Bioline, a Meridian Bioscience company, this week launched the EPIK Quantification and EPIK Amplification kits.

Sygnis said this week that Qiagen has launched the first two products of a series of kits based on Sygnis' proprietary SensiPhi amplification technology.

Meridian Bioscience today reported $44.8 million in preliminary revenue for its fiscal first quarter, marking a 1 percent decline from the year-ago period. Preliminary revenues included $34.8 million in sales from its Diagnostic segment, a 2 percent decline from fiscal Q1 2013.

RainDance Technologies this week announced it has added a high-precision chromosomal copy number variation measurement application to its RainDrop Digital PCR system.

Bio-Rad has launched PrimePCR assays for Droplet Digital PCR.

Bioline, a subsidiary of Meridian Bioscience, this week launched its Isolate II range of nucleic acid purification kits.

Meridian Bioscience said today that its Illumigene molecular diagnostic products accounted for 16 percent of its fiscal first quarter revenues, which increased 13 percent over the same quarter last year.

Pages

In Science this week: metagenomic-based technique for determining protein structure, and more.

An academic laments the rise of narcissism in the sciences, the Guardian reports.

Outgoing FDA commissioner Robert Califf writes in an editorial that the agency can help boost innovation.

The Trump transition team has asked NIH Director Francis Collins to remain at his post, though it's unclear for how long that will be.